Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Registry in Europe for the Use of CardioCel®, CardioCel® Neo and CardioCel® 3D

NCT04175327 is registered in ClinicalTrials.gov with LeMaitre Vascular as lead sponsor.

NCT NCT04175327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04175327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Registry in Europe for the Use of CardioCel®, CardioCel® Neo and CardioCel® 3D
Lead sponsor
LeMaitre Vascular
Phase
Observational
Overall status
Active, not recruiting
Start date
August 28, 2020
Completion date
March 31, 2026
Enrollment
200 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

great vessel reconstruction, intracardiac and septal defects, peripheral vessel reconstruction, suture line buttressing, valve and anulus repair